Foudi Nabil, Norel Xavier, Rienzo Mario, Louedec Liliane, Brink Charles, Michel Jean-Baptiste, Bäck Magnus
Bichat Hospital, 1INSERM U698, Paris Cedex 18, France.
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1882-8. doi: 10.1152/ajpheart.00092.2009. Epub 2009 Sep 25.
Although long-term use of cyclooxygenase (COX)-2 inhibitors may be associated with increased cardiovascular risk, their effects on vascular reactivity in atherosclerosis has remained largely unexplored. The aim of the present study was to evaluate the role of COX-2 induced by an atherosclerotic process, in the local control of vascular tone. New Zealand White rabbits were fed 0.3% cholesterol and subjected to balloon injury of the abdominal aorta. After 2 wk, the aorta was removed and used for organ bath experiments and immunohistochemistry, and the prostaglandins released were measured using enzyme immunoassays. Hypercholesterolemia and vascular injury significantly increased the thickness of the intimal layer, which was associated with an induction of COX-2 immunoreactivity throughout the aortic wall. In these preparations, a significant decrease of the maximal contractions induced by norepinephrine was observed. The norepinephrine-induced contractions of atherosclerotic preparations were restored by the COX inhibitors DuP-697 (0.5 micromol/l) and indomethacin (1.7 micromol/l), to similar contractions as was observed in aortic preparations derived from healthy rabbits. Norepinephrine stimulation of the abdominal aorta was accompanied by increased levels of prostaglandin I(2) but not of prostaglandin E(2), prostaglandin D(2), or thromboxane A(2) in atherosclerotic compared with normal aorta. Selective COX-2 inhibition significantly decreased the prostaglandin I(2) release from atherosclerotic aorta but had no effect on the prostaglandin release from aortic preparations derived from normal rabbits. These observations suggest that the local induction of COX-2 during atherosclerosis decreased the sensitivity to norepinephrine and that COX-2 inhibitors may increase vascular reactivity at sites of atherosclerotic lesions.
虽然长期使用环氧化酶(COX)-2抑制剂可能与心血管风险增加有关,但其对动脉粥样硬化中血管反应性的影响在很大程度上仍未得到探索。本研究的目的是评估动脉粥样硬化过程诱导的COX-2在局部血管张力控制中的作用。给新西兰白兔喂食0.3%的胆固醇,并对腹主动脉进行球囊损伤。2周后,取出主动脉用于器官浴实验和免疫组织化学,并用酶免疫分析法测量释放的前列腺素。高胆固醇血症和血管损伤显著增加了内膜层的厚度,这与整个主动脉壁COX-2免疫反应性的诱导有关。在这些标本中,观察到去甲肾上腺素诱导的最大收缩显著降低。COX抑制剂DuP-697(0.5微摩尔/升)和吲哚美辛(1.7微摩尔/升)使动脉粥样硬化标本中去甲肾上腺素诱导的收缩恢复到与健康兔主动脉标本中观察到的类似收缩水平。与正常主动脉相比,去甲肾上腺素刺激腹主动脉时,动脉粥样硬化主动脉中前列腺素I(2)水平升高,但前列腺素E(2)、前列腺素D(2)或血栓素A(2)水平未升高。选择性COX-2抑制显著降低了动脉粥样硬化主动脉中前列腺素I(2)的释放,但对正常兔主动脉标本中前列腺素的释放没有影响。这些观察结果表明,动脉粥样硬化期间COX-2的局部诱导降低了对去甲肾上腺素的敏感性,并且COX-2抑制剂可能会增加动脉粥样硬化病变部位的血管反应性。